DEPRECATED
This site is no longer maintained as of January 16th, 2013. Due to the increased security risks of this out-dated application , it will be decommissioned July 1st 2013. Please migrate use over to its replacement http://bioconnect.bio5.org. Direct questions and concerns to bio5admin@bio5.org. Thank you.
Michael Mayersohn
Professor
Selected Publications
Displaying 1 - 8 of 147
<< first < prev |
[1] |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
next >
last >>
. Dec 2007. Utility of the coefficient of determination (r2) in assessing the accuracy of interspecies allometric predictions: illumination or illusion?. Drug Metab Dispos, 35:2139-42
. Oct 2007. Interspecies prediction of human drug clearance based on scaling data from one or two animal species. Drug Metab Dispos, 35:1886-93
Pak Y, Stollberg-Zagar K, Mayersohn M. Jan 2006. A porcine model for fixed drug eruptions in humans: the case of antipyrine in the Yucatan micropig. J Appl Toxicol, 26:1-4
Tang H, Mayersohn M. Apr 2006. On the observed large interspecies overprediction of human clearance ("vertical allometry") of UCN-01: further support for a proposed model based on plasma protein binding. J Clin Pharmacol, 46:398-400
Tang H, Mayersohn M. Mar 2006. Response to comments on "a mathematical description of the functionality of correction factors used in allometry for predicting human drug clearance". Drug Metab Dispos, 34:510-1
Tang H Mayersohn M. Aug 2006. A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry. J Pharm Sci, 95:1783-99
Lund B, Seifert SA, Mayersohn M. Mar 2005. Efficacy of sustained low-efficiency dialysis in the treatment of salicylate toxicity. Nephrol Dial Transplant,2005 Mar 29;
Tang H, Mayersohn M. Sep 2005. A novel model for prediction of human drug clearance by allometric scaling. Drug Metab Dispos, 33:1297-303
Displaying 1 - 8 of 147
<< first < prev |
[1] |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
next >
last >>